GTBP Earnings

Quarterly EPS
$-38.25
Q3 2024
$-41.71
Q4 2024
$-8.25
Q1 2025
$-273.00
Q2 2025
$26.00
Q3 2025
$-62.44
Q4 2025
$-2.75
Q1 2026
$-3.00
Q2 2026
Latest RevenueN/A
Latest Net Income-4518000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.000-4518000—+98.9%
Q1 2026-$2.750-2833000—+66.7%
Q4 2025-$62.440-23031000—-49.7%
Q3 2025$26.0008.3M—+168.0%
Q2 2025-$273.000-30169000—-403.2%
Q1 2025-$8.250-776000—+79.9%
Q4 2024-$41.710-3775000—+9.8%
Q3 2024-$38.250-3411000—+13.6%
Q2 2024-$54.250-3710000——
Q1 2024-$41.000-2266000——
Q4 2023-$46.230-2962000——
Q3 2023-$44.250-2416000——
GT Biopharma (GTBP) — Earnings